KICL — Kalyani Investment Share News
0.000.00%
- IN₹21.66bn
- IN₹21.66bn
- IN₹780.54m
Brief: Kalyani Investment Appoints Anurag Jain As CEO And CFO
Brief: Kalyani Investment Company Says Shekhar Bhivpathaki Resigns As CEO & CFO
Kala Bio scraps development of eye disease drug after trial failure (updated)
KALA BIO scraps development of eye disease drug after trial failure
Brief: India's Kalyani Investment Posts Dec Qtr Profit
Brief: India's Kalyani Investment Co Sept-qtr PAT rises
Brief: Kalyani Investment bought 2.9 mln shares of Kalyani carpenter Special Steels
Brief: Kalyani Investment says ICICI Prudential MF cuts stake in co by 4.80 pct